Provexis Plc was established in 1999 as Provexis Limited. The company joined the Alternative Investment Market in 2005 and later graduated to the London Stock Exchange, where it trades with PXS as the stock symbol. Primarily, the reason for founding Provexis was to help commercialize Fruitflow®. Professor Asim Duttaroy is responsible for discovering the substance. Fruitflow® is anti-thrombotic, whereby it helps users to avoid blood clots. The product is offered in the form of syrup and powder. Users can consume Fruitflow® in food or beverages.

Provexis provides dietary supplements and functional food. Interestingly, most of the products produced by the company come from proprietary intellectual property. Presently, Fruitflow® is the lead product pushed by the company. The product was successfully launched in Europe and the US. Another product offered by Provexis is Fruitflow + Omega-3, which targets victims of abnormal heart function. The company is headquartered in Reading, the United Kingdom.

Latest Provexis News

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.